The FDA has approved the once-daily oral beta-3 adrenergic agonist mirabegron (Myrbetriq) for the
treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary
frequency.
Read the complete post at http://www.modernmedicine.com/modernmedicine/Enews/FDA-approves-overactive-bladder-agent-with-new-mec/ArticleStandard/Article/detail/780716?ref=25
Posted
Jul 11 2012, 12:00 AM
by
ModernMedicine